101 |
Cosmo Technologies Limited et al v. Mylan Pharmaceuticals Inc. |
1:16-cv-00040 |
N.D.W.Va. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
102 |
Cosmo Technologies Limited et al v. Mylan Pharmaceuticals Inc. |
1:16-cv-00040 |
N.D.W.Va. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
103 |
Gilead Sciences Inc. v. Mylan Pharmaceuticals Inc. |
1:16-cv-00192 |
D.Del. |
|
|
|
|
104 |
Takeda Pharmaceuticals U.S.A, Inc. v. Mylan Pharmaceuticals, Inc. |
1:16-cv-00202 |
N.D.W.Va. |
|
|
|
|
105 |
Forest Laboratories, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:16-cv-01114 |
D.Del. |
|
|
|
|
106 |
Forest Laboratories, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:16-cv-01114 |
D.Del. |
|
|
|
|
107 |
Forest Laboratories, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:16-cv-01114 |
D.Del. |
|
|
|
|
108 |
Forest Laboratories, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:16-cv-01114 |
D.Del. |
|
|
|
|
109 |
Gilead Sciences, Inc. v. Mylan Pharmaceuticals Inc. |
1:17-cv-00036 |
N.D.W.Va. |
|
|
|
|
110 |
Indivior Inc. et al v. Mylan Technologies Inc. et al |
1:17-cv-00157 |
N.D.W.Va. |
|
|
|
|
111 |
Indivior Inc. et al v. Mylan Technologies Inc. et al |
1:17-cv-00157 |
N.D.W.Va. |
|
|
|
|
112 |
Gilead Sciences, Inc. v. Mylan Pharmaceuticals Inc. |
1:17-cv-00187 |
D.Del. |
|
|
|
|
113 |
Gilead Sciences, Inc. v. Mylan Pharmaceuticals Inc. |
1:17-cv-00217 |
N.D.W.Va. |
|
|
|
|
114 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
115 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
116 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
117 |
Forest Laboratories, LLC et al v. Mylan Pharmaceuticals Inc. |
1:17-cv-01728 |
D.Del. |
|
|
|
|
118 |
Forest Laboratories, LLC et al v. Mylan Pharmaceuticals Inc. |
1:17-cv-01728 |
D.Del. |
|
|
|
|
119 |
Forest Laboratories, LLC et al v. Mylan Pharmaceuticals Inc. |
1:17-cv-01728 |
D.Del. |
|
|
|
|
120 |
Forest Laboratories, LLC et al v. Mylan Pharmaceuticals Inc. |
1:17-cv-01728 |
D.Del. |
|
|
|
|
121 |
Valeant Pharmaceuticals North America LLC et al v. Mylan Pharmaceuticals Inc. et al |
1:18-cv-00184 |
N.D.W.Va. |
|
|
|
|
122 |
Valeant Pharmaceuticals North America LLC et al v. Mylan Pharmaceuticals Inc. et al |
1:18-cv-00184 |
N.D.W.Va. |
|
|
|
|
123 |
Valeant Pharmaceuticals North America LLC et al v. Mylan Pharmaceuticals Inc. et al |
1:18-cv-00184 |
N.D.W.Va. |
|
|
|
|
124 |
Valeant Pharmaceuticals North America LLC et al v. Mylan Pharmaceuticals Inc. et al |
1:18-cv-00184 |
N.D.W.Va. |
|
|
|
|
125 |
Anacor Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. et al |
1:18-cv-00202 |
N.D.W.Va. |
|
|
|
|
126 |
Allergan Sales, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:18-cv-00226 |
N.D.W.Va. |
|
|
|
|
127 |
Allergan Sales, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:18-cv-00226 |
N.D.W.Va. |
|
|
|
|
128 |
Allergan Sales, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:18-cv-00226 |
N.D.W.Va. |
|
|
|
|
129 |
Allergan Sales, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:18-cv-00226 |
N.D.W.Va. |
|
|
|
|
130 |
Anacor Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. et al |
1:18-cv-01699 |
D.Del. |
|
|
|
|
131 |
Bausch Health US, LLC et al v. Mylan Pharmaceuticals Inc. |
1:20-cv-00046 |
N.D.W.Va. |
|
|
|
|
132 |
Bausch Health US, LLC et al v. Mylan Pharmaceuticals Inc. |
1:20-cv-00046 |
N.D.W.Va. |
|
|
|
|
133 |
Bausch Health US, LLC et al v. Mylan Pharmaceuticals Inc. |
1:20-cv-00046 |
N.D.W.Va. |
|
|
|
|
134 |
Bausch Health US, LLC et al v. Mylan Pharmaceuticals Inc. |
1:20-cv-00046 |
N.D.W.Va. |
|
|
|
|
135 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:20-cv-00090 |
N.D.W.Va. |
|
|
|
|
136 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:20-cv-00090 |
N.D.W.Va. |
|
|
|
|
137 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:20-cv-00090 |
N.D.W.Va. |
|
|
|
|
138 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:20-cv-00090 |
N.D.W.Va. |
|
|
|
|
139 |
Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. et al |
1:20-md-00445 |
D.Del. |
|
|
|
|
140 |
Mylan Pharmaceuticals Inc. v. Bayer Intellectual Property GMBH et al |
1:23-cv-00556 |
D.Del. |
|
|
|
|
141 |
Mylan Pharmaceuticals Inc. v. Bayer Intellectual Property GMBH et al |
1:23-cv-00556 |
D.Del. |
|
|
|
|
142 |
Mylan Pharmaceuticals Inc. v. Bayer Intellectual Property GMBH et al |
1:23-cv-00556 |
D.Del. |
|
|
|
|
143 |
SCHERING CORPORATION v. MYLAN PHARMACEUTICAL |
2:00-cv-01657 |
D.N.J. |
|
|
|
|
144 |
ASTRAZENECA UK LTD, et al v. MYLAN PHARMACEUTICAL |
2:00-cv-02239 |
W.D.Pa. |
|
|
|
|
145 |
ASTRAZENECA UK LTD, et al v. MYLAN PHARMACEUTICAL |
2:00-cv-02239 |
W.D.Pa. |
|
|
|
|
146 |
ORGANON INC., et al v. MYLAN PHARMACEUTICAL |
2:01-cv-03835 |
D.N.J. |
|
|
|
|
147 |
ORGANON INC., et al v. MYLAN PHARMACEUTICAL |
2:01-cv-03835 |
D.N.J. |
|
|
|
|
148 |
Alza Corporation, et al v. Mylan Laboratories, et al |
2:02-cv-00020 |
D.Vt. |
|
|
|
|
149 |
Alza Corporation, et al v. Mylan Laboratories, et al |
2:02-cv-00020 |
D.Vt. |
|
|
|
|
150 |
Alza Corporation, et al v. Mylan Laboratories, et al |
2:02-cv-00213 |
D.Vt. |
|
|
|
|